K2 HealthVentures
Derek Abel is a finance and healthcare management professional with extensive experience in the life sciences sector. Currently serving as a Principal at K2 HealthVentures since August 2019, Derek focuses on providing debt and equity capital to venture and growth stage companies. Prior roles include Senior Associate at Longitude Capital, where investments targeted biotechnology and medical technology companies, and Analyst at HealthCare Royalty Partners, a leading global healthcare private equity firm. Academic background includes a Bachelor of Science in Business Administration with majors in Finance and Healthcare Management from Washington University in St. Louis. Derek also has experience as a Teaching Assistant and various internship positions in finance and investment banking.
This person is not in any offices
K2 HealthVentures
K2 HealthVentures (K2HV) is an alternative investment firm that provides flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. We are healthcare specialists with deep domain expertise, and we understand both the opportunities and challenges that face venture-stage and growth-stage companies. Further, our flat organizational set-up enables nimble decision-making, and our evergreen fund structure allows us to be creative and adapt our facilities to a company’s specific needs over both the short and the long term. Over the last 4 years we have committed more than $1 billion in debt and equity capital to both private and public companies, and our team’s track record spans decades of investing in and supporting innovative life sciences and healthcare companies (with over $4 billion total investments in over 100 portfolio companies).